Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition).
作者信息
Shi Yi, Huang Yi, Zhang Tian-Tuo, Cao Bin, Wang Hui, Zhuo Chao, Ye Feng, Su Xin, Fan Hong, Xu Jin-Fu, Zhang Jing, Lai Guo-Xiang, She Dan-Yang, Zhang Xiang-Yan, He Bei, He Li-Xian, Liu You-Ning, Qu Jie-Ming
机构信息
Department of Pulmonary and Critical Care Medicine, Nanjing Jinling Hospital, Nanjing University, School of Medicine, Nanjing 210002, China.
Department of Pulmonary and Critical Care Medicine, Shanghai Changhai hospital, Navy Medical University, Shanghai 200433, China.
出版信息
J Thorac Dis. 2019 Jun;11(6):2581-2616. doi: 10.21037/jtd.2019.06.09.
Abstract
摘要
相似文献
1
Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition).
J Thorac Dis. 2019 Jun;11(6):2581-2616. doi: 10.21037/jtd.2019.06.09.
2
Descriptive Epidemiology and Outcomes of Nonventilated Hospital-Acquired, Ventilated Hospital-Acquired, and Ventilator-Associated Bacterial Pneumonia in the United States, 2012-2019.
Crit Care Med. 2022 Mar 1;50(3):460-468. doi: 10.1097/CCM.0000000000005298.
3
New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe.
Curr Opin Crit Care. 2018 Oct;24(5):347-352. doi: 10.1097/MCC.0000000000000535.
4
How to translate the new hospital-acquired and ventilator-associated pneumonia guideline to the bedside.
Curr Opin Crit Care. 2017 Oct;23(5):355-363. doi: 10.1097/MCC.0000000000000434.
5
Probable Non-Ventilator-Associated Hospital-Acquired Pneumonia: A Case Report.
Crit Care Nurse. 2024 Apr 1;44(2):49-58. doi: 10.4037/ccn2024693.
6
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT).
Eur Respir J. 2017 Sep 10;50(3). doi: 10.1183/13993003.00582-2017. Print 2017 Sep.
7
Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia.
Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S48-53. doi: 10.1086/653049.
8
Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.
Can J Infect Dis Med Microbiol. 2008 Jan;19(1):19-53. doi: 10.1155/2008/593289.
9
A Comparison of the Mortality Risk Associated With Ventilator-Acquired Bacterial Pneumonia and Nonventilator ICU-Acquired Bacterial Pneumonia.
Crit Care Med. 2019 Mar;47(3):345-352. doi: 10.1097/CCM.0000000000003553.
10
Prophylactic oral health procedures to prevent hospital-acquired and ventilator-associated pneumonia: a systematic review.
Int J Nurs Stud. 2015 Jan;52(1):452-64. doi: 10.1016/j.ijnurstu.2014.07.010. Epub 2014 Jul 27.
引用本文的文献
1
Sulbactam Concentration in Critically Ill Patients with Hospital-Acquired Pneumonia: A Comparisons Stratified by Normal and Augmented Renal Clearance.
Infect Drug Resist. 2025 Sep 4;18:4731-4739. doi: 10.2147/IDR.S538120. eCollection 2025.
2
Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future.
Front Pharmacol. 2025 Aug 7;16:1600787. doi: 10.3389/fphar.2025.1600787. eCollection 2025.
3
Intraoperative hypotension and postoperative pneumonia in patients after selective intracranial tumor resection: a retrospective cohort study.
PeerJ. 2025 Aug 4;13:e19514. doi: 10.7717/peerj.19514. eCollection 2025.
4
Evaluation of the Efficacy of a Nomogram to Predict Multidrug-Resistant Pulmonary Infections Based on Data from Neurosurgery Ward Patients.
Infect Drug Resist. 2025 Jul 26;18:3723-3734. doi: 10.2147/IDR.S527114. eCollection 2025.
5
Risk factors analysis and prediction model construction of hospital-acquired pneumonia after traumatic brain injury.
Front Neurol. 2025 Jul 10;16:1518599. doi: 10.3389/fneur.2025.1518599. eCollection 2025.
6
Incidence, risk factors, and predictive modeling of pulmonary infection after high-risk surgery for lung cancer: a retrospective case-control study.
J Thorac Dis. 2025 Jun 30;17(6):3702-3715. doi: 10.21037/jtd-2024-2276. Epub 2025 Jun 10.
7
Comparative study on the effect of different high-frequency chest wall oscillation and back patting modes on sputum excretion in patients with severe pneumonia.
Front Med (Lausanne). 2025 May 27;12:1558861. doi: 10.3389/fmed.2025.1558861. eCollection 2025.
8
Predicting infections with multidrug-resistant organisms (MDROs) in neurocritical care patients with hospital-acquired pneumonia (HAP): development of a novel multivariate prediction model.
Microbiol Spectr. 2025 Jun 3;13(6):e0246024. doi: 10.1128/spectrum.02460-24. Epub 2025 May 15.
9
Pulmonary infection after esophageal cancer surgery: impact on the reality, risk factors and development of a predictive nomogram.
World J Surg Oncol. 2025 Apr 21;23(1):149. doi: 10.1186/s12957-025-03806-1.
10
Integrated multi-omics reveals metabolic determinants of CRAB ST2 airway infection progression.
Microbiol Spectr. 2025 Jun 3;13(6):e0019525. doi: 10.1128/spectrum.00195-25. Epub 2025 Apr 16.
本文引用的文献
1
Multi-level analysis of bacteria isolated from inpatients in respiratory departments in China.
J Thorac Dis. 2018 May;10(5):2666-2675. doi: 10.21037/jtd.2018.04.46.
2
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT).
Eur Respir J. 2017 Sep 10;50(3). doi: 10.1183/13993003.00582-2017. Print 2017 Sep.
3
Synergistic activities of meropenem double and triple combinations against carbapenemase-producing Enterobacteriaceae.
Diagn Microbiol Infect Dis. 2017 Aug;88(4):355-360. doi: 10.1016/j.diagmicrobio.2017.04.015. Epub 2017 May 3.
4
Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia.
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00883-17. Print 2017 Aug.
5
Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial.
Chin Med J (Engl). 2017 May 20;130(10):1196-1201. doi: 10.4103/0366-6999.205846.
6
Precision Metagenomics: Rapid Metagenomic Analyses for Infectious Disease Diagnostics and Public Health Surveillance.
J Biomol Tech. 2017 Apr;28(1):40-45. doi: 10.7171/jbt.17-2801-007. Epub 2017 Mar 21.
7
Viral Pneumonia in Patients with Hematologic Malignancy or Hematopoietic Stem Cell Transplantation.
Clin Chest Med. 2017 Mar;38(1):97-111. doi: 10.1016/j.ccm.2016.11.002. Epub 2016 Dec 16.
8
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.
Intensive Care Med. 2017 Mar;43(3):304-377. doi: 10.1007/s00134-017-4683-6. Epub 2017 Jan 18.
9
Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes.
Int J Antimicrob Agents. 2017 Feb;49(2):224-232. doi: 10.1016/j.ijantimicag.2016.10.025. Epub 2016 Dec 23.
10
A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia: IASIS Trial.
Chest. 2017 Jun;151(6):1239-1246. doi: 10.1016/j.chest.2016.11.026. Epub 2016 Nov 24.
Zotero 插件